Evidence map›Paper›PMID 3516469›Full record

ArticleClinical and experimental immunology1986

Patterns of autoreactivity to collagen type II in autoimmune MRL/l mice.

A Tarkowski, R Holmdahl, K Rubin, L Klareskog, L A Nilsson, K Gunnarsson

Open access · greenAbstract read
In one paragraph

Article in Clinical and experimental immunology, 1986. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Rheumatoid arthritis: a synovial disease?Annals of the rheumatic diseases · 1999
    Review
  5. Article
  6. Article
  7. An idiotypic network model of AIDS immunopathogenesis.Proceedings of the National Academy of Sciences of the United States of America · 1991
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

A Tarkowski
R Holmdahl
K Rubin
L Klareskog
L A Nilsson
K Gunnarsson

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The kinetics and mechanisms for secretion of antibodies against native and denatured collagen type II have been studied in spontaneously arthritic MRL/l mice. Circulating antibodies were quantified by an ELISA assay and frequencies of specific antibody secreting spleen cells by an ELISPOT assay. The degree of humoral immunity to collagen type II increased at late stages of the disease (6 months of age) whereas severe synovitis was seen earlier (5 months of age). Both the appearance of anti-collagen II producing cells and development of synovitis was preceded by and not correlated with a general state of polyclonal B cell activation. In MRL/l mice, collagen II specific antibodies appeared spontaneously and titres were largely unaffected by collagen II immunization. The levels of circulating anti-collagen II antibodies in MRL/l mice were lower, and the antibodies displayed lower avidities and different specificities as compared with the antibodies generated in collagen II high responder DBA/l mice after immunization with collagen II. It is suggested that the antibody response in MRL/l mice against collagen type II does not need MHC-restricted T cell help and that induction of antibody production to collagen II in MRL/l mice is triggered by joint cartilage destruction and subsequent collagen II release.

Indexed as

AgingAnimalsAntibody AffinityAntibody-Producing CellsArthritisAutoantibodiesAutoimmune DiseasesCollagenFemaleImmunoenzyme TechniquesImmunoglobulin GMaleMiceMice, Inbred StrainsAutoantibodiesCollagenImmunoglobulin G

Identifiers

PMID3516469
PMCPMC1577362
OpenAlexW273512326

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.